13F-HR filed by NISA INVESTMENT ADVISORS, LLC
NISA INVESTMENT ADVISORS, LLC filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-01-17, with 3,006 holding rows worth $25,785,799,430.
- Accession
- 0000937615-25-000002
- Filer
- CIK 937615
- Filed
- 2025-01-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, 3,132 entries on the cover page, a total value of $25,785,799,430 stated on the cover page (in dollars after the unit check, H1), rows summing to $25,785,799,430 with VALUE read as dollars as filed, 13F file number 028-04668. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerWashington University
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BLUE RIDGE BANKSHARES INC | 095825105 | COMMON STOCK | 7 | $23 | dollars as filed | |
| ISPIRE TECHNOLOGY INC | 46501C100 | CMN | 2 | $10 | dollars as filed | |
| ALTABA INC COM | 021esc017 | COM | 72,703 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
| OMNIAB OPERATIONS INC | 68218J202 | RIGHT | 250 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
| ESC GCI LIBERTY INC SHS | 361ESC049 | Common Stock | 93,294 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
| Merrimack Pharmaceuticals Inc | 590328209 | Common / Ordinary Stock | 15 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000937615-25-000002 | this filing | 2025-01-17 | acceptance time not in the bulk data set |